Senior insider sale
EVP, General Counsel, Corp Sec at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$20.3K
3.75K shares
What this filing means
DE VERNEUIL VANINA plans to sell 3.75K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $20.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/5/2025ACC: 0001959173-25-006744
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
3.75K
Shares to sell
$20.3K
Approx. market value
2.38K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/1/2025
2.38KTotal acquired2.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2025 | Restricted Stock Vesting Compensation | 2.38K | — |
| Total | 2.38K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.36K
Market value
$8.0K
11/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.38K
Market value
$12.3K
11/5/2025
Total
Units
3.75K
Value
$20.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/3/2025 | 1.36K | $8.0K | — | Completed |
| Planned — Approximate Date | ||||
11/5/2025 | 2.38K | $12.3K | NASDAQ | Planned |
| Total | 3.75K | $20.3K | ||